Abstract
Systems biology has emerged as a major trend in biological research during the past decade. As living organisms are described in more and more detail, it aims at filling the gap between understanding basic molecular processes and complex biological systems in which new properties often emerge from the combination of these elementary processes. This approach culminates in the development of computer-based mathematical models of physiological and pathophysiological processes. We review the state of the art in dynamic modelling, with emphasis on two complementary approaches: the modelling of small systems that is mostly developed by academic teams and aims at understanding generic biological properties, and the modelling of large systems that is mostly implemented by industrial companies and aims at the generation of new therapeutic strategies. We also provide an example of such large-scale modelling applied to the identification of drug targets for neurodegeneration.
Keywords: Systems biology, models, transcriptomics, proteomics, data mining, bioinformatics
Current Pharmaceutical Design
Title: In Silico Dynamic Molecular Interaction Networks for the Discovery of New Therapeutic Targets
Volume: 16 Issue: 20
Author(s): Todor Vujasinovic, Andre Sinisa Zampera, Pascale Jackers, Despina Sanoudou and Antoine Depaulis
Affiliation:
Keywords: Systems biology, models, transcriptomics, proteomics, data mining, bioinformatics
Abstract: Systems biology has emerged as a major trend in biological research during the past decade. As living organisms are described in more and more detail, it aims at filling the gap between understanding basic molecular processes and complex biological systems in which new properties often emerge from the combination of these elementary processes. This approach culminates in the development of computer-based mathematical models of physiological and pathophysiological processes. We review the state of the art in dynamic modelling, with emphasis on two complementary approaches: the modelling of small systems that is mostly developed by academic teams and aims at understanding generic biological properties, and the modelling of large systems that is mostly implemented by industrial companies and aims at the generation of new therapeutic strategies. We also provide an example of such large-scale modelling applied to the identification of drug targets for neurodegeneration.
Export Options
About this article
Cite this article as:
Vujasinovic Todor, Sinisa Zampera Andre, Jackers Pascale, Sanoudou Despina and Depaulis Antoine, In Silico Dynamic Molecular Interaction Networks for the Discovery of New Therapeutic Targets, Current Pharmaceutical Design 2010; 16 (20) . https://dx.doi.org/10.2174/138161210791792822
DOI https://dx.doi.org/10.2174/138161210791792822 |
Print ISSN 1381-6128 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-4286 |

- Author Guidelines
- Bentham Author Support Services (BASS)
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Relationship Between Susceptibility to DMCM-Induced Generalized Motor Convulsions and Low-Affinity [3H]-Ouabain Binding in Membranes in Rat Brain
Current Molecular Pharmacology Erythropoietin: A Neuroprotective Agent in Cerebral Hypoxia, Neurodegeneration, and Epilepsy
Current Pharmaceutical Design Recent Advances in Epilepsy
Current Neuropharmacology Recent Trends in the Discovery of Small Molecule Blockers of Sodium Channels
Current Medicinal Chemistry Prediction of Disease-Related Genes Based on Hybrid Features
Current Proteomics Synthesis and Evaluation of In Vivo Anticonvulsant Activity of 2,5- Disubstituted-1,3,4-Oxadiazole Derivatives
Letters in Drug Design & Discovery Recent Inventions on Receptor Tyrosine Kinase RET Modulation
Recent Patents on Biotechnology Adverse Reactions to Fluoroquinolones. An Overview on Mechanistic Aspects
Current Medicinal Chemistry Safety and Efficacy of Levetiracetam for the Management of Levodopa- Induced Dyskinesia in Patients with Parkinson’s Disease: A Systematic Review
CNS & Neurological Disorders - Drug Targets Physiology, Pharmacology and Pathophysiology of the pH Regulatory Transport Proteins NHE1 and NBCn1: Similarities, Differences, and Implications for Cancer Therapy
Current Pharmaceutical Design Microemulsions and Nanoemulsions for Targeted Drug Delivery to the Brain
Current Nanoscience Nanostructures for Drug Delivery to the Brain
Current Medicinal Chemistry Combined Virtual Screening Strategies
Current Computer-Aided Drug Design Serotonergic and Cholinergic Strategies as Potential Targets for the Treatment of Schizophrenia
Current Pharmaceutical Design Heart Rate Variability Based Prediction of Personalized Drug Therapeutic Response: The Present Status and the Perspectives
Current Topics in Medicinal Chemistry Valproic acid, A Potential Inducer of Osteogenesis in Mouse Mesenchymal Stem Cells
Current Molecular Pharmacology Metabolic Changes in Rat Plasma After Epilepsy by UPLC-MS/MS
Current Pharmaceutical Analysis Sugars that Glow in the Dark: Fluorescent Tagged Glucose Bioprobes and their Facilitation of the Drug Discovery Process
Current Medicinal Chemistry Anesthesia Issues in Central Nervous System Disorders
Current Aging Science Mutations of mtDNA in some Vascular and Metabolic Diseases
Current Pharmaceutical Design